CDTG CDT Environmental Technology Investment Holdings Ltd Annual reports only
Sanitary Services · Nasdaq · SEC CIK 1793895 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-38.8%
TTM net income YoY-801.7%
TTM EPS YoY-700.0%
Revenue 3-yr CAGR-14.2%
Net income 3-yr CAGR—
Margins
Gross margin41.5%
Operating margin-63.9%
Net margin-55.9%
FCF margin-8.2%
EBITDA margin-62.6%
Returns
ROE-30.0%
ROA-11.4%
ROIC (approx.)-27.2%
Asset turnover0.20x
Leverage & solvency
Liabilities / assets65.5%
Debt / equity0.00x
Current ratio1.46x
Interest coverage-127.41x
Cash quality & payout
Operating cash flow / net income0.15x
Accruals ratio-9.8%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $18.23M | $29.77M |
| Cost of revenue | $10.67M | $18.52M |
| Gross profit | $7.56M | $11.25M |
| R&D expense | $47,602 | $61,786 |
| SG&A expense | $2.16M | $2.16M |
| Operating income | -$11.65M | $2.00M |
| Interest expense | $91,446 | $136,757 |
| Pretax income | -$11.63M | $1.87M |
| Income tax | -$1.27M | $462,043 |
| Net income | -$10.20M | $1.45M |
| EBITDA | -$11.42M | $2.26M |
| EPS (basic) | -0.84 | 0.14 |
| EPS (diluted) | -0.84 | 0.14 |
| Weighted avg. shares (diluted) | 12.14M | 10.32M |
| Balance sheet | ||
| Cash & equivalents | $66,686 | $124,379 |
| Receivables | $44.13M | $45.19M |
| Current assets | $84.32M | $77.70M |
| PP&E, net | $1.09M | $1.29M |
| Intangibles | — | $5,628 |
| Total assets | $88.90M | $89.36M |
| Current liabilities | $57.91M | $51.71M |
| Total liabilities | $58.26M | $51.92M |
| Shareholders' equity | $30.61M | $37.28M |
| Shares outstanding | — | 10.82M |
| Cash flow statement | ||
| Operating cash flow | -$1.49M | -$1.99M |
| Capital expenditure | $2,233 | $3,893 |
| Free cash flow | -$1.49M | -$1.99M |
| Investing cash flow | $1,067 | $545,167 |
| Financing cash flow | $1.40M | $1.02M |
| Depreciation & amortization | $235,099 | $263,109 |
| Stock-based compensation | $2.15M | $454,250 |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.